| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 17, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 325,000 | $1.66 | $540,364.43 | - | |
| Apr 17, 2020 | GH Guardant Health, Inc. | Eltoukhy Helmy76 | Chief Executive Officer | Sell | 15,904 | $70.22 | $1,116,738.82 | -0.2% | |
| Apr 16, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 25,000 | $1.63 | $40,737.97 | - | |
| Apr 16, 2020 | GH Guardant Health, Inc. | Eltoukhy Helmy76 | Chief Executive Officer | Sell | 2,901 | $70.06 | $203,242.24 | - | |
| Apr 15, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 200,000 | $1.55 | $309,376.63 | - | |
| Apr 14, 2020 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 2,689 | $70.00 | $188,230.00 | -67.4% | |
| Apr 14, 2020 | XWEL Xwell, Inc. | Heyer Andrew R67 | Former Director And 10% Owner | Sell | 4,112,020 | $0.38 | $1,553,687.80 | -38.7% | |
| Apr 13, 2020 | GH Guardant Health, Inc. | Meresman Stanley J75 | Director | Sell | 9,500 | $66.62 | $632,890.00 | -87.9% | |
| Apr 7, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 400,000 | $1.28 | $510,983.57 | - | |
| Apr 3, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 50,000 | $1.15 | $57,592.26 | - | |
| Apr 3, 2020 | EXAS Exact Sciences Corp | Stenhouse Mark | President, Cologuard | Sell | 11,948 | $56.69 | $677,332.12 | -28.8% | |
| Apr 2, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 500,000 | $1.16 | $581,184.79 | - | |
| Apr 2, 2020 | GH Guardant Health, Inc. | Talasaz Amirali | Chairman, President And COO | Sell | 25,000 | $67.03 | $1,675,816.29 | -0.3% | |
| Apr 1, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 643,549 | $1.23 | $793,012.26 | - | |
| Mar 31, 2020 | GH Guardant Health, Inc. | Eltoukhy Helmy76 | Chief Executive Officer | Sell | 281,196 | $70.16 | $19,729,106.99 | -1.2% | |
| Mar 31, 2020 | IMDX Insight Molecular Diagnostics Inc. | Andrews Ronald Asbury | CEO And President | Buy | 45,216 | $945.63 | $42,757,453.73 | +72.7% | |
| Mar 30, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 161,968 | $1.35 | $218,037.12 | - | |
| Mar 27, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.40 | $139,975.50 | - | |
| Mar 26, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 200,000 | $1.38 | $275,445.42 | - | |
| Mar 26, 2020 | PRPH Prophase Labs, Inc. | Karkus Ted William | CEO &Chairman | Sell | 100,000 | $1.75 | $175,000.00 | -3.8% | |
| Mar 26, 2020 | PRPH Prophase Labs, Inc. | Gleckel Louis Md | Director | Buy | 100,000 | $1.75 | $175,000.00 | +91.0% | |
| Mar 25, 2020 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 538 | $70.00 | $37,660.00 | -29.2% | |
| Mar 24, 2020 | GH Guardant Health, Inc. | Bertocci Derek A | Chief Financial Officer | Sell | 19,214 | $60.68 | $1,165,855.59 | -2.7% | |
| Mar 19, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.49 | $148,871.28 | - | |
| Mar 18, 2020 | RDNT Radnet, Inc. | Karen B. Kaplan Survivor's Trust | Indirect Owner | Buy | 10,000 | $5.99 | $59,900.00 | +90.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.